United Kingdom scientists will have access to the world’s largest research collaboration program, Horizon Europe, as the Prime Minister secures a bespoke deal with improved financial terms for the UK’s participation. UK researchers can now apply for grants and bid to take part in projects under the Horizon program, with certainty that the UK will...
Eli Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
[Ed. note: This post has been updated with a comment from Leonard C. Glass, MD, FACE, senior vice president, Lilly Diabetes and Obesity, Global Medical Affairs, Eli Lilly and Company] Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps...
The Time Is Always Now: The Endocrine Society’s Call to Eliminate Racism in Endocrinology
Never Too Late to Do Good: The Redemption of Stanley Andrisse, PhD, MBA
Endocrine Society’s In-Training Exam Predicts Fellows’ Success on ABIM Board Exam
Endocrinology fellows and their program directors can use performance on the Endocrine Society’s in-training self-assessment tool to gauge how likely fellows are to pass the American Board of Internal Medicine-Endocrinology, Diabetes, and Metabolism Certification Examination (ABIM-ECE), according to a new study published in the Journal of the Endocrine Society. The study found clinical endocrinology fellows’...
Devil in the Details: The Impact of the First Interchangeable Biosimilar Insulin
[Editor’s Note: This post has been updated to include comments from Rita Kalyani, MD.] When the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product last month, many were hailing this as a breakthrough in treating diabetes. The impacts could be immediately felt by people rationing their insulin due to cost as...